Advances in resuscitation strategies

International Journal of Surgery

Volumn 9, Issue 1, 2011, Pages 5-12

  Alam, Hasan B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bleeding; Blood; Fluids; Hemorrhage; Resuscitation; Sepsis; Shock

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; DEXTRAN; DIASPIRIN CROSSLINKED HEMOGLOBIN; DOPAMINE; FRESH FROZEN PLASMA; HEMOGLOBIN; HISTONE DEACETYLASE INHIBITOR; HYPERTENSIVE AGENT; IMMUNOMODULATING AGENT; INFUSION FLUID; INOTROPIC AGENT; NALOXONE; NORADRENALIN; OPIATE ANTAGONIST; PENTOXIFYLLINE; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; POLYMERIZED HEMOGLOBIN; PROSTAGLANDIN; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; STEROID; VALPROIC ACID; VASOPRESSIN; VORINOSTAT;

ADJUVANT THERAPY; BLEEDING; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; BRAIN DAMAGE; BURN; CLINICAL PRACTICE; CRITICALLY ILL PATIENT; CRYSTALLOID; DEATH; EMERGENCY TREATMENT; EVIDENCE BASED PRACTICE; FLUID THERAPY; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HEMORRHAGIC SHOCK; HUMAN; HYPOTENSION; IMMUNE SYSTEM; INDUCED HYPOTHERMIA; INFECTION RISK; INJURY; INTENSIVE CARE UNIT; MEAN ARTERIAL PRESSURE; META ANALYSIS (TOPIC); MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; NONHUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT SAFETY; PENETRATING TRAUMA; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; REVIEW; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; SHOCK; SURGICAL PATIENT; SURVIVAL; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

HUMANS; RESUSCITATION; SHOCK, SURGICAL;

EID: 78651094105     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2010.09.001     Document Type: Review

References (139)

1. Sauaia A., Moore F.A., Moore E.E., Moser K.S., Brennan R., Read R.A., et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995, 38:185-193.
2. Acosta J.A., Yang J.C., Winchell R.J., Simons R.K., Fortlage D.A., Hollingsworth-Fridlund P., et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998, 186:528-533.
3. Kaweski S.M., Sise M.J., Virgilio R.W. The effect of prehospital fluids on survival in trauma patients. J Trauma 1990, 30:1215-1218.
4. Turner J., Nicholl J., Webber L., Cox H., Dixon S., Yates D. A randomized controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess 2000, 4:1-57.
5. Greaves M.W., Hussein S.H. Fluid resuscitation in pre-hospital trauma care: a consensus view. J R Coll Surg Edinb 2002, 47:451-457.
6. Dula D.J., Wood G.C., Rejmer A.R., Starr M., Leicht M. Use of prehospital fluids in hypotensive blunt trauma patients. Prehosp Emerg Care 2002, 6:417-420.
7. Dutton R.P., Mackenzie C.F., Scalea T.M. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 2002, 52:1141-1146.
8. Cannon W.B., Faser J., Collew E.M. The preventive treatment of wound shock. JAm Med Assoc 1918, 47:618.
9. Stern S.A., Dronen S.C., Birrer P., Wang X. Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med 1993, 22:155-163.
10. Selby J.B., Mathis J.E., Berry C.F., Hagedorn F.N., Illner H.P., Shires G.T. Effects of isotonic saline solution resuscitation on blood coagulation in uncontrolled hemorrhage. Surgery 1996, 119:528-533.
11. Sondeen J.L., Coppes V.G., Holcomb J.B. Blood pressure at which rebleeding occurs after resuscitation in swine with aortic injury. J Trauma 2003, 54(Suppl):S100-S107.
12. Rotondo M.F., Schwab C.W., McGonigal M.D., Phillips G.R., Fruchterman T.M., Kauder D.R., et al. " Damage Control": an approach for improved survival in exsanguinating penetrating abdominal trauma. J Trauma 1993, 35:375-383.
13. Mapstone J., Roberts I., Evans P. Fluid resuscitation strategies: a systematic review of animal trials. J Trauma 2003, 55:571-589.
14. Liberman M., Mulder D., Sampalis J. Advanced or basic life support for trauma: meta-analysis and critical review of the literature. J Trauma 2000, 49:584-599.
15. Bickel W.H., Wall M.J., Pepe P.E., Martin R.R., Ginger V.F., Allen M.K., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994, 331:1105-1109.
16. Kwan I., Bunn F., Roberts I. WHO pre-hospital trauma care steering committee: timing and volume of fluid administration for patients with bleeding following trauma. Cochrane Database Syst Rev 2003, (3):CD002245.
17. Alam H.B. An update on fluid resuscitation. Scand J Surg 2006, 95:136-145.
18. Committee on fluid resuscitation for combat casualties Fluid resuscitation: state of the science for treating combat casualties and civilian trauma. Report of the Institute of Medicine 1999, National Academy Press, Washington, DC.
19. Shires G.T., Carrico C.J., Baxter C.R., Giesecke A.H., Jenkins M.T. Principles in treatment of severely injured patients. Adv Surg 1970, 4:255-324.
20. Shires G.T., Coln D., Carrico J., Lightfoot S. Fluid therapy in hemorrhagic shock. Arch Surg 1964, 88:688-693.
21. Dillon J., Lunch L.J., Myers R., Butcher H.R., Moyer C.A. A bioassay of treatment of hemorrhagic shock. Arch Surg 1966, 93:537-555.
22. Cervera A.L., Moss G. Progressive hypovolumia leading to shock after continous hemorrhage and 3:1 crystalloid replacement. Am J Surg 1975, 129:670-674.
23. Alam H.B., Rhee P. New developments in fluid resuscitation. Surg Clin North Am 2007, 87:55-72.
24. Cotton B.A., Guy J.S., Morris J.A., Abumrad N.N. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006, 26:115-121.
25. Daugherty E.L., Hongyan Liang, Taichman D., Hansen-Flaschen J., Fuchs B.D. Abdominal compartment syndrome is common in medical intensive care unit patients receiving large volume resuscitation. J Intensive Care Med 2007, 22:294-299.
26. O'Mara M.S., Slater H., Goldfarb I.W., Caushaj P.F. A prospective, randomized evaluation of intra-abdominal pressures with crystalloids and colloid resuscitation in burn patients. J Trauma 2005, 58:1011-1018.
27. Balogh Z., Moore F.A., Moore E.E., Biffl W.L. Secondry abdominal compartment syndrome: a potential threat for all trauma clinicians. Injury 2007, 38:272-279.
28. Klein M.B., Hayden D., Elson C., Nathens A.B., Gamelli R.L., Gibran N.S., et al. The association between fluid administeration and outcome following major burn. A multicenter study. Ann Surg 2007, 245:622-628.
29. Uniformed Services University of the Health Sciences Combat Fluid Resuscitation June 18-20, 2001, Sponsored by US Office of Naval Research; US Army Medical Research and Material Command; Department of Surgery, Department of Military and Emergency Medicine, Bethesda, MD.
30. Defense and Civil Institute of Environmental Medicine Fluid Resuscitation in Combat October 25-26, 2001, Sponsored by Defense R & D Canada, Defense and Civil Institute of Environmental Medicine, Department of Surgery, University of Toronto; and the Office of Naval Research, Toronto, Ontario.
31. Champion H.R. Combat fluid resuscitation: introduction and overview of conferences. J Trauma 2003, 54(Suppl.):7-12.
32. Rhee P., Koustova E., Alam H.B. Searching for the optimal resuscitation method: recommendations for the initial fluid resuscitation of combat casualties. J Trauma 2003, 54(Suppl.):52-62.
33. Gwande A. Casualties of war - military care for the wounded from Iraq and Afghanistan. New Engl J Med 2004, 351:2471-2475.
34. Varela J.E., Cohn S.M., Diaz I., Giannotti G.D., Proctor K.G. Splanchnic perfusion during delayed, hypotensive, or aggressive fluid resuscitation from uncontrolled hemorrhage. Shock 2003, 20:476-480.
35. Lu Y.Q., Cai X.J., Gu L.H., Wang Q., Huang W.D., Bao D.G. Experimental study of controlled fluid resuscitation in the treatment of severe and uncontrolled hemorrhagic shock. J Trauma 2007, 63:798-804.
36. Xiao N., Wang X.C., Diao Y.F., Liu R., Tian K.L. Effect of initial fluid resuscitation on subsequent treatment in uncontrolled hemorrhagic shock in rats. Shock 2004, 21:276-280.
37. Skarda D.E., Mulier K.E., George M.E., Beilman G.J. Eight hours of hypotensive versus normotensive resuscitation in a porcine model of controlled hemorrhagic shock. Acad Emerg Med 2008, 15:845-852.
38. Rafie A.D., Rath P.A., Michell M.W., Kirschner R.A., Deyo D.J., Prough D.S., et al. Hypotensive resuscitation of multiple hemorrhages using crystalloid and colloids. Shock 2004, 22:262-269.
39. Shah K.J., Chiu W.C., Scalea T.M., Carlson D.E. Detrimental effects of rapid fluid resuscitation on hepatocellular function and survival after hemorrhagic shock. Shock 2002, 18:242-247.
40. Knoferl M.W., Angele M.K., Ayala A., Cioffi W.G., Bland K.I., Chaudry I.H. Do different rates of fluid resuscitation adversely or beneficially influence immune responses after trauma-hemorrhage?. J Trauma 1999, 46:23-33.
41. Santibanez-Gallerani A.S., Barber A.E., Williams S.J., Zhao B.S.Y., Shires G.T. Improved survival with early fluid resuscitation following hemorrhagic shock. World J Surg 2001, 25:592-597.
42. Haas B., Nathens A.B. Pro/con debate: is the scoop and run approach the best approach to trauma services organization?. Crit Care 2008, 12:224-235.
43. Velasco I.T., Ponieri V., Rocha M., Lopes O.U. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol 1980, 239:H664.
44. DeFelippe J., Timoner I.J., Velasco I.T., Lopes O.U., Rocha-e-Silva M. Treatment of refractory hypovolemic shock by 7.5% sodium chloride injections. Lancet 1980, 2:1002.
45. Bunn F., Roberts I., Tasker R. Hypertonic versus near isotonic crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2004, 3. CD002045.
46. Wade C.E., Kramer G.C., Grady J.J., Fabian T.C., Younes R.N. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery 1997, 122:609-616.
47. Junger W.G., Coimbra R., Liu F.C., Herdon-Remelius C., Junger W., Junger H., et al. Hypertonic saline resuscitation: a tool to modulate immune function in trauma patients?. Shock 1997, 8:235-241.
48. Rotstein O.D. Novel strategies for immunomodulation after trauma: revisiting hypertonic saline as a resuscitation strategy for hemorrhagic shock. J Trauma 2000, 49:580-583.
49. Bahrami S., Zimmermann K., Szelenyi Z., Hamar J., Scheiflinger F., Redl H., et al. Small volume fluid resuscitation with hypertonic saline prevents inflammation but not mortality in a rat model of hemorrhagic shock. Shock 2006, 25:283-289.
50. Pascual J.L., Ferri L.E., Seely A.J., Campisi G., Chaudhury P., Giannias B., et al. Hypertonic saline resuscitation of hemorrhagic shock diminishes neutrophil rolling and adherence to endothelium and reduces in vivo vascular leakage. Ann Surg 2002, 236:634-642.
51. Murao Y., Loomis W., Wolf P., Hoyt D.B., Junger W.G. Effect of hypertonic saline on its potential to prevent lung tissue damage in a mouse model of hemorrhagic shock. Shock 2003, 20:29-34.
52. Murao Y., Hata M., Ohnishi K., Okuchi K., Nakajima Y., Hiasa Y., et al. Hypertonic saline resuscitation reduces apoptosis and tissue damage of the small intestine in a mouse model of hemorrhagic shock. Shock 2003, 20:23-28.
53. Sheppard F.R., Moore E.E., McLaughlin N., Kelher M., Johnson J.L., Silliman C.C. Clinically relevant osmolar stress inhibits priming-induced PMN NADPH oxidase subunit translocation. J Trauma 2005, 58:752-757.
54. Gonzales R.J., Moore E.E., Ciesla D.J., Neto J.R., Biffl W.L., Silliman C.C. Hyperosmolarity abrogates neutrophil cutotoxity provoked by post-shock mesenteric lymph. Shock 2002, 18:29-32.
55. Staudenmayer K.L., Maier R.V., Jelacic S., Bulger E.M. Hypertonic saline modulates innate immunity in a model of systemic inflammation. Shock 2005, 23:459-463.
56. Cuschieri J., Gourlay D., Garcia I., Jelacic S., Maier R.V. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol 2002, 168:1389-1396.
57. Bulger E.M., Cuschieri J., Warner K., Maier R.V. Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock. Ann Surg 2007, 245:635-641.
58. Available at:. https://roc.uwctc.org/tiki/tiki-index.php.
59. The NHLBI halts study of concentrated saline for patients with shock due to lack of survival benefit NIH News [serial on the Internet] Available at:, [accessed on 05.04.10]. http://www.nih.gov/news/health/mar2009/nhlbi-26.htm.
60. The SAFE Study Investigators Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007, 357:874-884.
61. Holcomb J.B., Jenkins D., Rhee P., Johannigman J., Mahoney P., Mehta S., et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007, 62:307-310.
62. Gonzalez E.A., Moore F.A., Holcomb J.B., Miller C.C., Kozar R.A., Todd S.R., et al. Fresh frozen plasma should be given earlier to patients receiving massive transfusion. J Trauma 2007, 62:112-119.
63. Borgman M.A., Spinella P.C., Perkins J.G., Grathwohl K.W., Repine T., Beekley A.C., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813.
64. Duchesne J.C., Hunt J.P., Wahl G., Marr A.B., Wang Y.Z., Weintraub S.E., et al. Review of current blood transfusions strategies in a mature level i trauma center: were we wrong for the last 60 years?. J Trauma 2008, 65:272-276.
65. Holcomb J.B., Wade C.E., Michalek J.E., Chisholm G.B., Zarzabal L.A., Schreiber M.A., et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008, 248:447-458.
66. Snyder C.W., Weinberg J.A., McGwin G., Melton S.M., George R.L., Reiff D.A., et al. The relationship of blood product ratio to mortality: survival benefit or survival bias?. J Trauma 2009, 66:358-362.
67. Malone D.L., Hess J.R., Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006, 60:S91-S96.
68. Cotton B.A., Gunter O.L., Isbell J., Au B.K., Robertson A.M., Morris J.A., et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008, 64:1177-1182.
69. Dente C.J., Shaz B.H., Nicholas J.M., Harris R.S., Wyrzykowski A.D., Patel S., et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 2009, 66:1616-1624.
70. Silliman C.C., Moore E.E., Johnson J.L., Gonzales R.J., Biffl W.L. Transfusion of the injured patient: proceed with caution. Shock 2004, 21:291-299.
71. Charles A., Shaikh A.A., Walters M., Huehl S., Pomerantz R. Blood transfusion in an independent predictor of mortality after blunt trauma. Am Surg 2007, 73:1-5.
72. Offner P.J., Moore E.E., Biffl W.L., Johnson J.L., Silliman C.C. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002, 137:711-717.
73. Dunne J.R., Malone D.L., Tracy J.K., Napolitano L.M. Allogenic blood transfusion in the first 24 h after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect (Larchmt) 2004, 5:395-404.
74. Moore F.A., Moore E.E., Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997, 132:620-624.
75. Moore E.E. Blood substitutes: the future is now. J Am Coll Surg 2003, 196:1-17.
76. Sloan E.P., Koenigsberg M., Gens D., Cipolle M., Runge J., Mallory M.N., et al. Diaspirin cross-linked hemoglobin (dclhb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAm Med Assoc 1999, 282:1857-1864.
77. Kerner T., Ahlers O., Veit S., Riou B., Saunders M., Pison U. Dcl-hb for trauma patients with severe hemorrhagic shock: the european " On-scene" Multicenter study. Intensive Care Med 2003, 29:378-385.
78. Moore E.E., Moore F.A., Fabian T.C., Bernard A.C., Fulda G.J., Hoyt D.B., et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg 2009, 208:1-13.
79. Natanson C., Kern S.J., Lurie P., Banks S.M., Wolfe S.M. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. J Am Med Assoc 2008, 299:2304-2312.
80. [accessed on 05.03.2010]. http://clinicaltrials.gov/ct2/show/NCT00301483%3Fterm%3DHBOC201&rank%3D1.
81. Jahr J.S., Mackenzie C., Pearce L.B., Pitman A., Greenburg A.G. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma 2008, 64:1484-1497.
82. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., et al. Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. Early Goal-Directed Therapy Collaborative Group.
83. Sebat F., Johnson D., Musthafa A.A., Watnik M., Moore S., Henry K., et al. A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest 2005, 127:1729-1743.
84. Kortgen A., Niederprum P., Bauer M. Implementation of an evidence based ″ standard operating procedure″ and outcome in septic shock. Crit Care Med 2006, 34:943-949.
85. Shapiro N.I., Howell M.D., Talmor D., Lahey D., Ngo L., Buras J., et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006, 34:1025-1032.
86. Nguyen H.B., Corbett S.W., Steele R., Banta J., Clark R.T., Hayes S.R., et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 2007, 35:1105-1112.
87. Shorr A.F., Micek S.T., Jackson W.L., Kollef M.H. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?. Crit Care Med 2007, 35:1257-1262.
88. SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256.
89. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
90. Hollenberg S.M., Ahrens T.S., Annane D., Astiz M.E., Chalfin D.B., Dasta J.F., et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004, 32:1928-1948.
91. LeDoux D., Astiz M.E., Carpati C.M., Rackow E.C. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000, 28:2729-2732.
92. Müllner M., Urbanek B., Havel C., Losert H., Waechter F., Gamper G. Vasopressors for shock. Cochrane Database Syst Rev 2004, (3). CD003709.
93. Russell J.A. Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care 2007, 13:383-391.
94. Russell J.A., Walley K.R., Singer J., Gordon A.C., Hébert P.C., Cooper D.J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887.
95. Hébert P.C., Wells G., Blajchman M.A., Marshall J., Martin C., Pagliarello G., et al. A multicenter, randomized, controlled clinical trial of transfusion in critical care. N Engl J Med 1999, 340:409-417.
96. Napolitano L.M., Kurek S., Luchette F.A., Corwin H.L., Barie P.S., Tisherman S.A., et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009, 37:3124-3157.
97. Yu H.P., Chaudry I.H. The role of estrogen and receptor agonists in maintaining organ function after trauma-hemorrhage. Shock 2009, 31:227-237.
98. Deree J., Martins J., de Campos T., Putnam J.G., Loomis W.H., Wolf P., et al. Pentoxifylline attenuates lung injury and modulates transcription factor activity in hemorrhagic shock. J Surg Res 2007, 143:99-108.
99. Boeuf B., Poirier V., Gauvin F., Guerguerian A.M., Roy C., Farrell C.A., et al. Naloxone for shock. Cochrane Database Syst Rev 2003, CD004443.
100. Lin T., Alam H.B., Chen H., Britten-Webb J., Rhee P., Kirkpatrick J., et al. Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation. Surgery 2006, 139:365-376.
101. Alam H.B., Shults C., Ahuja N., Ayuste E.C., Chen H., Koustova E., et al. Impact of resuscitation strategies on the acetylation status of cardiac histones in a swine model of hemorrhage. Resuscitation 2008, 76:299-310.
102. Gonzales E.R., Chen H., Munuve R.M., Mehrani T., Nadel A., Koustova E. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock. J Trauma 2008, 65:554-565.
103. Shults C., Sailhamer E.A., Li Y., Liu B., Tabbara M., Butt M.U., et al. Surviving blood loss without fluid resuscitation. J Trauma 2008, 64:629-638.
104. Alam H., Shuja F., Butt M., Duggan M., Li Y., Zacharias N., et al. Surviving blood loss without blood transfusion in a swine poly-trauma model. Surgery 2009, 146:325-333.
105. Sailhamer E.A., Li Y., Smith E.J., Shuja F., Shults C., Liu B., et al. Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans. Surgery 2008, 144:204-216.
106. Li Y., Yuan Z., Liu B., Sailhamer E.A., Shults C., Velmahos G.C., et al. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. J Trauma 2008, 64:863-870.
107. Li Y., Liu B., Sailhamer E.A., Yuan Z., Shults C., Velmahos G.C., et al. Cell protective mechanism of valproic acid in lethal hemorrhagic shock. Surgery 2008, 144:217-224.
108. Butt M., Sailhamer E., Li Y., Liu B., Shuja F., Velmahos G., et al. Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock. J Surg Res 2009, 156:290-296.
109. Li Y., Liu B., Zhao H., Sailhamer E., Zhang X., Kheirbek T., et al. Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents. Shock 2009, 146:325-333.
110. Demetriades D., Murray J., Charalambides K., Alo K., Velmahos G., Rhee P., et al. Trauma fatalities: time and location of hospital deaths. J Am Coll Surg 2004, 198:20-26.
111. Tisherman S.A., Safar P., Radovsky A., Peitzman A., Sterz F., Kuboyama K. Therapeutic deep hypothermic circulatory arrest in dogs: a resuscitation modality for hemorrhagic shock with ″ irreparable injury″ J Trauma 1990, 30:836-847.
112. °C) improves neurologic outcome in dogs after two hours circulatory arrest induced to enable resuscitative surgery. J Trauma 1991, 31:1051-1062.
113. Capone A., Safar P., Radovsky A., Wang Y.F., Peitzman A., Tisherman S.A. Complete recovery after normothermic hemorrhagic shock and profound hypothermic circulatory arrest of 60 min in dogs. J Trauma 1996, 40:388-395.
114. Behringer W., Prueckner S., Kentner R., Tisherman S.A., Radovsky A., Clark R., et al. Rapid hypothermic aortic flush can achieve survival without brain damage after 30 min cardiac arrest in dogs. Anesthesiology 2000, 93:1491-1499.
115. Behringer W., Safar P., Wu X., et al. Survival without brain damage after clinical death of 60-120 min in dogs using suspended animation by profound hypothermia. Crit Care Med 2003, 31:1523-1531.
116. Taylor M.J., Bailes J.E., Elrifai A.M., Shih S.R., Teeple E., Leavitt M.L., et al. A new solution for life without blood: asanguineous low-flow perfusion of a whole body perfusate during 3 hours of cardiac arrest and profound hypothermia. Circulation 1995, 91:431-444.
117. Rhee P., Talon E., Eifert S., Anderson D., Stanton K., Koustova E., et al. Induced hypothermia during emergency department thoracotomy: an animal model. J Trauma 1999, 48:439-449.
118. Alam H.B., Bowyer M.W., Koustova E., et al. Learning and memory is preserved following induced asanguineous hyperkalemic hypothermic arrest in a swine model of traumatic exsanguination. Surgery 2002, 132:278-288.
119. Alam H.B., Chen Z., Honma K., Koustova E., Querol R.I., Jaskille A., et al. The rate of induction of hypothermic arrest determines the outcome in a swine model of lethal hemorrhage. J Trauma 2004, 57:961-969.
120. Alam H.B., Rhee P., Honma K., Chen H., Ayuste E.C., Lin T., et al. Does the rate of rewarming from profound hypothermic arrest influences the outcome in a swine model of lethal hemorrhage. J Trauma 2006, 60:134-146.
121. Chen Z., Chen H., Rhee P., Koustova E., Ayuste E.C., Honma K., et al. Induction of profound hypothermia modulates the immune/inflammatory response in a swine model of lethal hemorrhage. Resuscitation 2005, 66(2):209-216.
122. Alam H.B., Chen Z., Ahuja N., Chen H., Conran R., Ayuste E.C., et al. Profound hypothermia preserves neurons and astrocytes, and protects cognitive functions in a swine model of lethal hemorrhage. J Surg Res 2005, 126:172-181.
123. Shuja F., Tabbara M., Li Y., Liu B., Butt M.U., Velmahos G.C., et al. Profound hypothermia decreases cardiac apoptosis through Akt survival pathway. J Am Coll Surg 2009, 209(1):89-99.
124. Alam H.B., Chen Z., Li Y., Velmahos G., DeMoya M., Keller C.E., et al. Profound hypothermia is superior to ultra-profound hypothermia in improving survival in a swine model of lethal injuries. Surgery 2006, 140:307-314.
125. Alam H.B., Duggan M., Li Y., et al. Putting life on hold-for how long? profound hypothermic cardiopulmonary bypass in a swine model of complex vascular injuries. J Trauma 2008, 64:912-922.
126. Sailhamer E.A., Chen Z., Ahuja N., Velmahos G.C., de Moya M., Rhee P., et al. Profound hypothermic cardiopulmonary bypass facilitates survival without a high complication rate in a swine model of complex vascular, splenic and colon injuries. J Am Coll Surg 2007, 204:642-653.
127. Casas F., Alam H., Reeves A., Chen Z., Smith W.A. A suspended animation forward lines casualty management system. Artif Organs 2005, 29:557-563.
128. Taylor M.J., Rhee P., Chen Z., Alam H.B. Design of preservation solutions for universal tissue preservation in vivo: demonstration of efficacy in pre-clinical models of profound hypothermic cardiac arrest. Transplant Proc 2005, 37:303-307.
129. Kheirbek T., Kochanek A.R., Alam H.B. Hypothermia in bleeding trauma: a friend or a foe?. Scand J Trauma Resusc Emerg Med 2009 Dec 23, 17(1):65. [Epub ahead of print].
130. Alam H.B., Hashmi S., Finkelstein R.A., Shuja F., Fukudome E.Y., Li Y., et al. Alterations in gene expression after induction of profound hypothermia for the treatment of lethal hemorrhage. J Trauma 2010, [accepted].
131. Blackstone E., Morrison M., Roth M.B. H2S induces suspended animation-like state in mice. Science 2005, 308:518.
132. Fukudome E.Y., Alam H.B. Hypothermia in multisystem trauma. Crit Care Med 2009, 37(Suppl.):S265-S272.
133. [accessed on 05.04.2010]. http://clinicaltrials.gov/ct2/show/NCT01042015?term=EPR&rank=2.
134. Velmahos G.C., Alam H.B. Advances in surgical critical care. Curr Probl Surg 2008, 45:453-516.
135. Pepe P.E., Dutton R.P., Fowler R.L. Preoperative resuscitation of the trauma patient. Curr Opin Anaesthesiol 2008, 21:216-221.
136. Boldt J. Fluid choice for resuscitation of the trauma patient: a review of the physiological, pharmacological, and clinical evidence. Can J Anaesth 2004, 51:500-513.
137. Santry H., Alam H.B. Fluid resuscitation: past, present and the future. Shock 2010, 33:229-241.
138. Spoerke N., Zink K., Cho S.D., et al. Lyophalized plasma for resuscitation in a swine model of severe injuries. Arch Surg 2009, 144:829-834.
139. Shuja F., Shults C., Duggan M., Tabbara M., Butt M.U., Fisher T.H., et al. Development and testing of freeze dried plasma for the treatment of trauma associated coagulopathy. J Trauma 2008, 65:975-985. 24.